和誉-B计划将公司名称更新为“和誉医药有限责任公司”

Stock News08-24

和誉-B（02256）近日发布公告，公司董事会已提议对现有名称体系进行调整。根据公告内容，和誉开曼有限责任公司的英文名称将由“Abbisko Cayman Limited”变更为“Abbisko Medicine Co., Ltd.”，同时其中文双重外文名称也将从“和誉开曼有限责任公司”同步更新为“和誉医药有限责任公司”。

此次名称变更提案旨在进一步优化公司品牌形象，并更好地反映其业务发展定位。目前该建议已正式提交，尚待相关程序批准后生效。市场投资者可关注后续公告以获取最新进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189249598?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-24 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189249598","market":"fut","top_or_hot":-1,"title":"和誉-B计划将公司名称更新为“和誉医药有限责任公司”","media":"Stock News","content":"<p>和誉-B（02256）近日发布公告，公司董事会已提议对现有名称体系进行调整。根据公告内容，<b>和誉开曼有限责任公司</b>的英文名称将由“Abbisko Cayman Limited”变更为“Abbisko Medicine Co., Ltd.”，同时其中文双重外文名称也将从“和誉开曼有限责任公司”同步更新为“和誉医药有限责任公司”。<br><br>此次名称变更提案旨在进一步优化公司品牌形象，并更好地反映其业务发展定位。目前该建议已正式提交，尚待相关程序批准后生效。市场投资者可关注后续公告以获取最新进展。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>和誉-B计划将公司名称更新为“和誉医药有限责任公司”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n和誉-B计划将公司名称更新为“和誉医药有限责任公司”\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-24 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>和誉-B（02256）近日发布公告，公司董事会已提议对现有名称体系进行调整。根据公告内容，<b>和誉开曼有限责任公司</b>的英文名称将由“Abbisko Cayman Limited”变更为“Abbisko Medicine Co., Ltd.”，同时其中文双重外文名称也将从“和誉开曼有限责任公司”同步更新为“和誉医药有限责任公司”。<br><br>此次名称变更提案旨在进一步优化公司品牌形象，并更好地反映其业务发展定位。目前该建议已正式提交，尚待相关程序批准后生效。市场投资者可关注后续公告以获取最新进展。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1189249598","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189249598","pubTimestamp":1787578523,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"和誉-B（02256）近日发布公告，公司董事会已提议对现有名称体系进行调整。根据公告内容，和誉开曼有限责任公司的英文名称将由“Abbisko Cayman Limited”变更为“Abbisko Medicine Co., Ltd.”，同时其中文双重外文名称也将从“和誉开曼有限责任公司”同步更新为“和誉医药有限责任公司”。此次名称变更提案旨在进一步优化公司品牌形象，并更好地反映其业务发展定位。目前该建议已正式提交，尚待相关程序批准后生效。市场投资者可关注后续公告以获取最新进展。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","BK1161":"生物科技","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","BK1574":"生物医药B类股","LU2778985437.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"A\" (USD) INC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","BK1515":"抗疫概念","09939":"开拓药业-B","LU2476274308.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (USD) ACC","LU2476274720.SGD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (SGDHDG) ACC","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC","02256":"和誉-B"},"translate_title":"和誉-B计划将公司名称更新为“和誉医药有限责任公司”","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"09939":1,"02256":1},"content_text":"和誉-B（02256）近日发布公告，公司董事会已提议对现有名称体系进行调整。根据公告内容，和誉开曼有限责任公司的英文名称将由“Abbisko Cayman Limited”变更为“Abbisko Medicine Co., Ltd.”，同时其中文双重外文名称也将从“和誉开曼有限责任公司”同步更新为“和誉医药有限责任公司”。此次名称变更提案旨在进一步优化公司品牌形象，并更好地反映其业务发展定位。目前该建议已正式提交，尚待相关程序批准后生效。市场投资者可关注后续公告以获取最新进展。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189249598","isCrawlerRequest":true}